Literature DB >> 30234235

[A case of severe metformin-associated lactic acidosis treated with CVVHDF and regional anticoagulation with sodium citrate].

Matteo Ferrario1, Antonio Apicella1, Mauro Della Morte1, Enrico Beretta1.   

Abstract

Metformin is an antidiabetic drug; used to treat type II diabetes mellitus, metformin associated lactic acidosis has an incidence of 2-9 cases / 100,000 patients / year with high mortality (30%). We have had the case of a 75-year-old woman with metabolic acidosis as a result of metformin assumption, treated by renal replacement therapy (CRRT) with continuous veno-venous hemodiafiltration (CVVHDF).
RESULTS: after a short treatment period there was a reduction in Lactates (from 16.8 mmol/L to 12.6 mmol/L) and a progressive improvement of acidosis. In 72 hours the recovery of diuresis and subsequent suspension of CRRT was achieved.
CONCLUSION: CRRT, in addition to ensuring support for renal failure and volume correction, allowed a rapid recovery from metformin-associated lactic acidosis. Copyright by Società Italiana di Nefrologia SIN, Rome, Italy.

Entities:  

Keywords:  lactic acidosis ; CRRT; CVVHDF; metformin

Mesh:

Substances:

Year:  2018        PMID: 30234235

Source DB:  PubMed          Journal:  G Ital Nefrol        ISSN: 0393-5590


  2 in total

1.  Do Patients Die with or from Metformin-Associated Lactic Acidosis (MALA)? Systematic Review and Meta-analysis of pH and Lactate as Predictors of Mortality in MALA.

Authors:  Adam Blumenberg; Roshanak Benabbas; Richard Sinert; Amy Jeng; Sage W Wiener
Journal:  J Med Toxicol       Date:  2020-01-06

2.  Extracorporeal membrane oxygenation with continuous renal replacement therapy to treat metformin-associated lactic acidosis: A case report.

Authors:  Ting Chen; Chunyan Zhu; Bao Liu
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.